Abevmy

Medicinal product

(Invented) name

Abevmy

Active substance (s)

Bevacizumabas

Strength

25 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FG01, Bevacizumab

Marketing authorisation holder

Biosimilar Collaborations Ireland Limited, Airija

Date of authorisation

2021-04-21

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 ml
Bevacizumabas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106382	92483	1092483	flakonas	4 ml N1		Receptinis	EU/1/20/1515/001	Netiekiama	-	-	No	-	-
106383	92484	1092484	flakonas	4 ml N5		Receptinis	EU/1/20/1515/002	Netiekiama	-	-	No	-	-
106384	92485	1092485	flakonas	16 ml N1		Receptinis	EU/1/20/1515/003	Netiekiama	-	-	No	-	-
106385	92486	1092486	flakonas	16 ml N2		Receptinis	EU/1/20/1515/004	Netiekiama	-	-	No	-	-
106386	92487	1092487	flakonas	16 ml N3		Receptinis	EU/1/20/1515/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-04-21	Registruotas